SPRY ARS Pharmaceuticals, Inc.
Nasdaq · SEC CIK 1671858 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $1.95M 4 sales by 4 insiders
- Filings on record
- 210 since 2021-09-21, latest 2026-09-02 17:27
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Chakma Justin | Chief Business Off | — | $1.48M |
| Karas Eric | Chief Commercial Off | — | $250.0K |
| Dorsey Brian | COO | — | $190.1K |
| Fitzpatrick Alexander A | CLO | — | $33.5K |
| Shah Pratik | Dir | — | — |
Transactions 170
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-05-16 | 2024-05-14+ | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | S - Sale | $9.06 | -100.0K | 1.75M | -5% | -$905.6K |
| MI | 2024-05-16 | 2024-05-14+ | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $9.06 | -100.0K | 1.64M | -6% | -$905.6K |
| MI | 2024-05-09 | 2024-05-07 | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | S - Sale | $9.34 | -100.0K | 1.80M | -5% | -$934.0K |
| MI | 2024-05-09 | 2024-05-07 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $9.34 | -100.0K | 1.80M | -5% | -$934.0K |
| DMI | 2024-04-24 | 2024-04-23 | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | M - OptEx | $1.06 | +131.0K | 3.36M | +4% | +$139.0K |
| DM | 2024-04-24 | 2024-04-23 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | M - OptEx | $1.06 | +131.0K | 3.36M | +4% | +$139.0K |
| DM | 2024-04-22 | 2024-04-19 | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | M - OptEx | $1.06 | +188.5K | 4.32M | +5% | +$200.0K |
| DMI | 2024-04-22 | 2024-04-19 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | M - OptEx | $1.06 | +188.5K | 4.25M | +5% | +$200.0K |
| MI | 2024-04-17 | 2024-04-16 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $9.28 | -100.0K | 1.65M | -6% | -$928.0K |
| MI | 2024-04-17 | 2024-04-16 | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | S - Sale | $9.28 | -100.0K | 1.65M | -6% | -$928.0K |
| MI | 2024-04-10 | 2024-04-09 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $9.28 | -100.0K | 1.90M | -5% | -$928.0K |
| MI | 2024-04-10 | 2024-04-09 | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | S - Sale | $9.28 | -100.0K | 1.90M | -5% | -$928.0K |
| MI | 2024-03-27 | 2024-03-25+ | SPRY | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | P - Purchase | $9.48 | +1.40M | 8.99M | +18% | +$13.29M |
| MI | 2024-03-26 | 2024-03-22+ | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | S - Sale | $9.12 | -97.6K | 1.70M | -5% | -$890.0K |
| MI | 2024-03-26 | 2024-03-22+ | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $9.12 | -97.6K | 2.00M | -5% | -$890.0K |
| MI | 2024-03-21 | 2024-03-19+ | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $9.03 | -2,390 | 1.75M | -0.1% | -$21.6K |
| MI | 2024-03-21 | 2024-03-19+ | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | S - Sale | $9.03 | -2,390 | 2.00M | -0.1% | -$21.6K |
| MI | 2024-03-15 | 2024-03-13+ | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | S - Sale | $9.14 | -100.0K | 1.70M | -6% | -$913.5K |
| MI | 2024-03-15 | 2024-03-13+ | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $9.14 | -100.0K | 1.74M | -5% | -$913.5K |
| MI | 2024-03-01 | 2024-02-29 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $9.01 | -3,782 | 2.05M | -0.2% | -$34.1K |
| MI | 2024-03-01 | 2024-02-29 | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | S - Sale | $9.01 | -3,782 | 2.05M | -0.2% | -$34.1K |
| MI | 2024-02-28 | 2024-02-26+ | SPRY | Lowenthal Richard E | Pres AND CEO, Dir, 10% | S - Sale | $9.02 | -99.5K | 1.77M | -5% | -$897.3K |
| MI | 2024-02-28 | 2024-02-26+ | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | S - Sale | $9.02 | -99.5K | 1.75M | -5% | -$897.3K |
| DMI | 2024-01-04 | 2023-05-17 | SPRY | Tanimoto Sarina | Chief Medical Off, 10% | G - Gift | $0.00 | +1.05M | 1.05M | New | $0 |
| D | 2024-01-04 | 2023-05-17 | SPRY | Tanimoto Sarina | Chief Medical Off, 10% | G - Gift | $0.00 | -1.05M | 3.28M | -24% | $0 |
| DMI | 2024-01-04 | 2023-05-17 | SPRY | Lowenthal Richard E | Pres, CEO, Dir, 10% | G - Gift | $0.00 | +1.05M | 1.05M | New | $0 |
| D | 2024-01-04 | 2023-05-17 | SPRY | Lowenthal Richard E | Pres, CEO, Dir, 10% | G - Gift | $0.00 | -1.05M | 4.13M | -20% | $0 |
| M | 2023-10-02 | 2023-09-28+ | SPRY | Fitzpatrick Alexander A | CLO | P - Purchase | $3.71 | +86.3K | 43.0K | New | +$319.7K |
| MI | 2023-09-25 | 2023-09-21 | SPRY | RA Capital Healthcare Fund LP | Dir | P - Purchase | $3.03 | +2.70M | 8.37M | +48% | +$8.18M |
| DM | 2023-09-05 | 2023-09-01 | SPRY | Shawver Laura | Dir | M - OptEx | $1.27 | +100.0K | 213.3K | +88% | +$127.0K |
| D | 2023-09-05 | 2023-09-01 | SPRY | Shawver Laura | Dir | S - Sale+OE | $7.71 | -100.0K | 210.3K | -32% | -$771.0K |
| I | 2023-08-31 | 2023-08-29 | SPRY | RA CAPITAL MANAGEMENT, L.P. | Dir | P - Purchase | $6.20 | +3.75M | 5.86M | +178% | +$23.25M |
| I | 2023-08-31 | 2023-08-29 | SPRY | OrbiMed Capital GP VI LLC | Dir | P - Purchase | $6.20 | +500.0K | 8.02M | +7% | +$3.10M |
| I | 2023-08-31 | 2023-08-29 | SPRY | Thompson Peter A. | Dir | P - Purchase | $6.20 | +500.0K | 8.02M | +7% | +$3.10M |
| DM | 2023-08-07 | 2023-08-03+ | SPRY | Shawver Laura | Dir | M - OptEx | $1.27 | +45.0K | 236.5K | +24% | +$57.2K |
| DM | 2023-08-07 | 2023-08-03+ | SPRY | Shawver Laura | Dir | S - Sale+OE | $7.03 | -45.0K | 210.3K | -18% | -$316.4K |
| DM | 2023-08-03 | 2023-08-01+ | SPRY | Shawver Laura | Dir | M - OptEx | $1.27 | +55.0K | 229.1K | +32% | +$69.8K |
| DM | 2023-08-03 | 2023-08-01+ | SPRY | Shawver Laura | Dir | S - Sale+OE | $7.12 | -55.0K | 210.3K | -21% | -$391.8K |
| D | 2023-07-07 | 2023-07-07 | SPRY | Shawver Laura | Dir | S - Sale+OE | $6.36 | -8,858 | 210.3K | -4% | -$56.3K |
| D | 2023-07-07 | 2023-07-07 | SPRY | Shawver Laura | Dir | M - OptEx | $1.27 | +8,858 | 219.2K | +4% | +$11.2K |
| DM | 2023-07-06 | 2023-07-03+ | SPRY | Shawver Laura | Dir | M - OptEx | $1.27 | +91.1K | 236.9K | +63% | +$115.8K |
| DM | 2023-07-06 | 2023-07-03+ | SPRY | Shawver Laura | Dir | S - Sale+OE | $6.48 | -91.1K | 210.3K | -30% | -$590.4K |
| DM | 2023-06-02 | 2023-06-01+ | SPRY | Shawver Laura | Dir | S - Sale+OE | $6.84 | -100.0K | 210.3K | -32% | -$684.0K |
| DM | 2023-06-02 | 2023-06-01+ | SPRY | Shawver Laura | Dir | M - OptEx | $1.27 | +100.0K | 237.3K | +73% | +$127.0K |
| DM | 2023-05-10 | 2022-11-09+ | SPRY | Shawver Laura | Dir | S - Sale+OE | $5.42 | -143.9K | 210.3K | -41% | -$780.6K |
| DM | 2023-05-10 | 2023-05-08+ | SPRY | Shawver Laura | Dir | M - OptEx | $1.27 | +100.0K | 267.4K | +60% | +$127.0K |
| I | 2022-12-01 | 2022-11-29 | SPRY | Scott Kathleen D. | CFO | P - Purchase | $6.24 | +8,250 | 8,250 | New | +$51.5K |
| I | 2022-11-10 | 2022-11-08 | SPRY | Dadoo Rajeev | Dir | A - Grant | — | +3.01M | 3.01M | New | — |
| D | 2022-11-10 | 2022-11-08 | SPRY | Chakma Justin | Chief Business Off | A - Grant | — | +236.4K | 236.4K | New | — |
| DI | 2022-11-10 | 2022-11-08 | SPRY | Shah Pratik | Dir, 10% | A - Grant | — | +10.16M | 10.16M | New | — |
| DI | 2022-11-10 | 2022-11-08 | SPRY | Kelly Michael | Dir | A - Grant | — | +83.2K | 83.2K | New | — |
| MI | 2022-11-10 | 2022-11-08 | SPRY | Shah Rajeev M. | Dir | A - Grant | — | +3.01M | 902.9K | New | — |
| DMI | 2022-11-10 | 2022-11-08 | SPRY | Lowenthal Richard E | Pres, CEO, Dir, 10% | A - Grant | — | +7.87M | 1.77M | New | — |
| D | 2022-11-10 | 2022-11-08 | SPRY | Lowenthal Richard E | Pres, CEO, Dir, 10% | A - Grant | — | +5.18M | 5.18M | New | — |
| DMI | 2022-11-10 | 2022-11-08 | SPRY | Tanimoto Sarina | Chief Medical Off, 10% | A - Grant | — | +7.87M | 1.77M | New | — |
| D | 2022-11-10 | 2022-11-08 | SPRY | Tanimoto Sarina | Chief Medical Off, 10% | A - Grant | — | +4.33M | 4.33M | New | — |
| D | 2022-08-09 | 2022-08-05 | SPRY | Shawver Laura | CEO, Dir | M - OptEx | $1.27 | +78.7K | 254.2K | +45% | +$100.0K |
| D | 2022-05-04 | 2022-05-02 | SPRY | Shawver Laura | CEO, Dir | A - Grant | $0.00 | +68.1K | 175.5K | +63% | $0 |
| D | 2022-05-04 | 2022-05-02 | SPRY | Piazza Jonathan | CFO | A - Grant | $0.00 | +43.7K | 69.2K | +171% | $0 |
| D | 2022-05-04 | 2022-05-02 | SPRY | Odegard Valerie | Pres, CSO | A - Grant | $0.00 | +45.2K | 61.6K | +276% | $0 |
| D | 2022-05-04 | 2022-05-02 | SPRY | Hawkinson Russ | Sr. VP of Fin | A - Grant | $0.00 | +28.3K | 37.3K | +318% | $0 |
| D | 2022-05-04 | 2022-05-02 | SPRY | Hunder Naomi | Chief Medical Off | A - Grant | $0.00 | +43.2K | 54.4K | +384% | $0 |
| MI | 2022-03-18 | 2021-03-03+ | SPRY | ROOT JONATHAN D | Dir | P - Purchase | $15.25 | +2,364 | 2,364 | New | +$36.0K |
| A | 2022-02-24 | 2020-12-08 | SPRY | Hawkinson Russ | Sr. VP of Fin | P - Purchase | $21.00 | +200 | 200 | New | +$4,200 |
| D | 2022-02-02 | 2022-02-01 | SPRY | Piazza Jonathan | CFO | A - Grant | $0.00 | +11.2K | 25.5K | +79% | $0 |
| D | 2022-02-02 | 2022-02-01 | SPRY | Shawver Laura | CEO, Dir | A - Grant | $0.00 | +27.5K | 107.4K | +34% | $0 |
| D | 2022-02-02 | 2022-02-01 | SPRY | Hunder Naomi | Chief Medical Off | A - Grant | $0.00 | +11.2K | 11.2K | New | $0 |
| D | 2022-02-02 | 2022-02-01 | SPRY | Odegard Valerie | Pres, CSO | A - Grant | $0.00 | +16.4K | 16.4K | New | $0 |
| D | 2022-02-02 | 2022-02-01 | SPRY | Hawkinson Russ | Sr. VP of Fin | A - Grant | $0.00 | +7,500 | 8,954 | +516% | $0 |
| MI | 2021-12-15 | 2021-12-13 | SPRY | ROOT JONATHAN D | Dir | J - Other | — | -2.17M | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations